Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3: Randomised Controlled Trial of Rituximab in Active Ulcerative Colitis

NCT00261118 is registered in ClinicalTrials.gov with Royal Liverpool University Hospital as lead sponsor.

NCT NCT00261118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00261118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3: Randomised Controlled Trial of Rituximab in Active Ulcerative Colitis
Lead sponsor
Royal Liverpool University Hospital
Phase
Phase 2/3
Overall status
Completed
Start date
April 30, 2004
Completion date
October 31, 2009
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis